|
17
|
117
|
8vsjH |
Engineered peptide-specific binder in complex with hla-dr1/clip |
|
35
|
190
|
8vsjB |
Engineered peptide-specific binder in complex with hla-dr1/clip |
|
20
|
107
|
8vsjL |
Engineered peptide-specific binder in complex with hla-dr1/clip |
|
43
|
119
|
8vsjC |
Engineered peptide-specific binder in complex with hla-dr1/clip |
|
31
|
179
|
8vsjA |
Engineered peptide-specific binder in complex with hla-dr1/clip |
|
31
|
188
|
8vrwB |
Cryo-em structure of human invariant chain in complex with hla-dr15 |
|
15
|
56
|
8vrwC |
Cryo-em structure of human invariant chain in complex with hla-dr15 |
|
28
|
180
|
8vrwA |
Cryo-em structure of human invariant chain in complex with hla-dr15 |
|
34
|
178
|
8tbpA |
Hla-drb1*15:01 in complex with smith antigen |
|
41
|
189
|
8tbpB |
Hla-drb1*15:01 in complex with smith antigen |
|
41
|
189
|
7o00BBB |
Crystal structure of hla-dr4 in complex with a hsp70 peptide |
|
38
|
189
|
7nzfBBB |
Crystal structure of hla-dr4 in complex with a mutated human collagen type ii peptide |
|
45
|
189
|
7nzhBBB |
Crystal structure of hla-dr4 in complex with a citrullinated cilp peptide |
|
31
|
177
|
7o00AAA |
Crystal structure of hla-dr4 in complex with a hsp70 peptide |
|
32
|
180
|
7nzhAAA |
Crystal structure of hla-dr4 in complex with a citrullinated cilp peptide |
|
35
|
180
|
7nzfAAA |
Crystal structure of hla-dr4 in complex with a mutated human collagen type ii peptide |
|
40
|
194
|
8cmbB |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s486-505 |
|
41
|
189
|
8cmfB |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp3 epitope (orf1ab)1350-1364 |
|
44
|
192
|
8cmgB |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp14 peptide (orf1ab)6420-6434 |
|
0
|
14
|
8cmbC |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s486-505 |
|
35
|
180
|
8cmbA |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s486-505 |
|
36
|
182
|
8cmgA |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp14 peptide (orf1ab)6420-6434 |
|
35
|
180
|
8cmhA |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s486-505 |
|
33
|
183
|
8cmiA |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s761-775 |
|
40
|
194
|
8cmhB |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s486-505 |
|
0
|
14
|
8cmhC |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s486-505 |
|
45
|
191
|
8cmeB |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 membrane peptide m176-190 |
|
34
|
182
|
8cmeA |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 membrane peptide m176-190 |
|
0
|
14
|
8cmcC |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s511-530 |
|
34
|
181
|
8cmfA |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp3 epitope (orf1ab)1350-1364 |
|
40
|
190
|
8cmdB |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s761-775 |
|
0
|
15
|
8cmeC |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 membrane peptide m176-190 |
|
42
|
191
|
8cmiB |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 omicron (ba.1) spike peptide s761-775 |
|
33
|
183
|
8cmdA |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s761-775 |
|
47
|
192
|
8cmcB |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s511-530 |
|
35
|
182
|
8cmcA |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 spike peptide s511-530 |
|
0
|
15
|
8cmgC |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp14 peptide (orf1ab)6420-6434 |
|
40
|
222
|
8euqC |
Crystal structure of hla-dra*01:01/hla-drb1*04:01 in complex with c44h10 fab |
|
42
|
216
|
8euqB |
Crystal structure of hla-dra*01:01/hla-drb1*04:01 in complex with c44h10 fab |
|
29
|
185
|
8euqA |
Crystal structure of hla-dra*01:01/hla-drb1*04:01 in complex with c44h10 fab |
|
43
|
212
|
8euqD |
Crystal structure of hla-dra*01:01/hla-drb1*04:01 in complex with c44h10 fab |
|
33
|
178
|
7z0qC |
Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange |
|
35
|
188
|
7z0qD |
Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange |
|
49
|
192
|
7yxbB |
Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange |
|
47
|
193
|
7yx9B |
Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange |
|
36
|
181
|
7yxbA |
Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange |
|
35
|
179
|
7yx9A |
Mhc-ii dynamics are maintained in hla-dr allotypes to ensure catalyzed peptide exchange |
|
42
|
190
|
7nzeBBB |
Crystal structure of hla-dr4 in complex with a human collagen type ii peptide |
|
35
|
179
|
7nzeAAA |
Crystal structure of hla-dr4 in complex with a human collagen type ii peptide |
|
35
|
179
|
7n19A |
Dr3 in complex with aspergillus nidulans nad-dependent histone deacetylase hst4 peptide |
